Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 107.20
-1.10 (-1.02%)
At close: Aug 13, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 24.76 billion as of August 14, 2026. Its market cap has increased by 0.47% in one year.
Market Cap
24.76B
Enterprise Value
33.80B
Revenue
15.57B
Ranking
n/a
PE Ratio
17.00
Stock Price
107.20
ChartMarket Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 24.76B, an increase of 24.24%. That is a compound annual growth rate of 1.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 24.76B | 2.49% |
| Dec 30, 2025 | 24.16B | -23.03% |
| Dec 30, 2024 | 31.39B | -44.53% |
| Dec 28, 2023 | 56.60B | -14.34% |
| Dec 29, 2022 | 66.07B | 17.50% |
| Dec 30, 2021 | 56.23B | 210.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 194.31B |
| Beximco Pharmaceuticals PLC. | 65.94B |
| Renata | 54.10B |
| Unilever Consumer Care | 39.32B |
| The ACME Laboratories | 17.61B |
| Asiatic Laboratories | 14.34B |
| The IBN SINA Pharmaceutical Industry | 10.07B |
| Navana Pharmaceuticals | 7.45B |